Literature DB >> 16817850

Melatonin: Nature's most versatile biological signal?

S R Pandi-Perumal1, V Srinivasan, G J M Maestroni, D P Cardinali, B Poeggeler, R Hardeland.   

Abstract

Melatonin is a ubiquitous molecule and widely distributed in nature, with functional activity occurring in unicellular organisms, plants, fungi and animals. In most vertebrates, including humans, melatonin is synthesized primarily in the pineal gland and is regulated by the environmental light/dark cycle via the suprachiasmatic nucleus. Pinealocytes function as 'neuroendocrine transducers' to secrete melatonin during the dark phase of the light/dark cycle and, consequently, melatonin is often called the 'hormone of darkness'. Melatonin is principally secreted at night and is centrally involved in sleep regulation, as well as in a number of other cyclical bodily activities. Melatonin is exclusively involved in signaling the 'time of day' and 'time of year' (hence considered to help both clock and calendar functions) to all tissues and is thus considered to be the body's chronological pacemaker or 'Zeitgeber'. Synthesis of melatonin also occurs in other areas of the body, including the retina, the gastrointestinal tract, skin, bone marrow and in lymphocytes, from which it may influence other physiological functions through paracrine signaling. Melatonin has also been extracted from the seeds and leaves of a number of plants and its concentration in some of this material is several orders of magnitude higher than its night-time plasma value in humans. Melatonin participates in diverse physiological functions. In addition to its timekeeping functions, melatonin is an effective antioxidant which scavenges free radicals and up-regulates several antioxidant enzymes. It also has a strong antiapoptotic signaling function, an effect which it exerts even during ischemia. Melatonin's cytoprotective properties have practical implications in the treatment of neurodegenerative diseases. Melatonin also has immune-enhancing and oncostatic properties. Its 'chronobiotic' properties have been shown to have value in treating various circadian rhythm sleep disorders, such as jet lag or shift-work sleep disorder. Melatonin acting as an 'internal sleep facilitator' promotes sleep, and melatonin's sleep-facilitating properties have been found to be useful for treating insomnia symptoms in elderly and depressive patients. A recently introduced melatonin analog, agomelatine, is also efficient for the treatment of major depressive disorder and bipolar affective disorder. Melatonin's role as a 'photoperiodic molecule' in seasonal reproduction has been established in photoperiodic species, although its regulatory influence in humans remains under investigation. Taken together, this evidence implicates melatonin in a broad range of effects with a significant regulatory influence over many of the body's physiological functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817850     DOI: 10.1111/j.1742-4658.2006.05322.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  200 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 4.  The circadian control of skin and cutaneous photodamage.

Authors:  Joshua A Desotelle; Melissa J Wilking; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2012-02-21       Impact factor: 3.421

Review 5.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 6.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 7.  Neuroendocrine-immune correlates of circadian physiology: studies in experimental models of arthritis, ethanol feeding, aging, social isolation, and calorie restriction.

Authors:  Ana I Esquifino; Pilar Cano; Vanesa Jiménez-Ortega; Pilar Fernández-Mateos; Daniel P Cardinali
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

8.  Melatonin attenuates hLRRK2-induced long-term memory deficit in a Drosophila model of Parkinson's disease.

Authors:  Dongzhi Ran; Baogang Xie; Zongjie Gan; Xicui Sun; Huaiyu Gu; Junqing Yang
Journal:  Biomed Rep       Date:  2018-07-05

9.  Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats.

Authors:  Qing-hua Zhang; Zhan-song Zhou; Gen-sheng Lu; Bo Song; Jian-xin Guo
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

10.  Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1.

Authors:  Sylvia Aust; Walter Jäger; Harald Kirschner; Martin Klimpfinger; Theresia Thalhammer
Journal:  Wien Med Wochenschr       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.